GFM
COGT icon

GF Fund Management’s Cogent Biosciences COGT Stock Holding History

GF Fund Management’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$133K Buy
3,447
+431
+14% +$15.9K ﹤0.01% 313
2025
Q4 		$107K Buy
3,016
+10
+0.3% +$281 ﹤0.01% 340
2025
Q3 		$43.2K Buy
3,006
+178
+6% +$2.11K ﹤0.01% 411
2025
Q2 		$20.3K Hold
2,828
– – ﹤0.01% 502
2025
Q1 		$16.9K Buy
2,828
+509
+22% +$3.99K ﹤0.01% 518
2024
Q4 		$18.1K Buy
+2,319
New +$23.1K ﹤0.01% 483

Other funds holding COGT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

GF Fund Management's COGT Position: Q1 2026 in Review

GF Fund Management increased its Cogent Biosciences (COGT) stake by 14% in Q1 2026, buying an estimated $15.9K and bringing the position to 3,447 shares worth $133K. The position accounts for ﹤0.01% of the portfolio, ranked #313.

GF Fund Management first reported a position in COGT in Q4 2024 and has held it in 6 quarters since. 305 funds tracked by Wall St. Rank hold COGT as of Q1 2026.

  • GF Fund Management held 3,447 shares of Cogent Biosciences worth $133K as of Q1 2026.
  • GF Fund Management bought 431 Cogent Biosciences shares in Q1 2026, an estimated $15.9K.
  • Cogent Biosciences made up ﹤0.01% of GF Fund Management's portfolio in Q1 2026, its #313 holding.
  • GF Fund Management first reported a position in Cogent Biosciences in Q4 2024 and has held it in 6 quarters since.
  • 305 funds tracked by Wall St. Rank held Cogent Biosciences as of Q1 2026.

Based on GF Fund Management's 13F filing for Q1 2026, filed 15 Apr 2026.